1-7 of 7
Nadia Cecconi
Close
Sort by
Journal Articles

The Impact of Different Mobilization Strategies in the Setting of Multiple Myeloma

Francesco Mazziotta, MD, Gabriele Buda, MD PhD, Nadia Cecconi, MD, Giulia Cervetti, MD, Lorenzo Iovino, MD, Enrico Orciuolo, MD PhD, Matteo Pelosini, MD PhD, Edoardo Benedetti, MD, Francesco Caracciolo, MD, Giovanni Carulli, MD, Sara Galimberti, MD PhD, Mario Petrini, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3254.
https://doi.org/10.1182/blood-2019-126118
Published: 2019
Journal Articles

Coagulopathy in Patients with Plasmacellular Dyscrasia

Francesca Martini, Gabriele Buda, MD PhD, Nadia Cecconi, Dr, Laura Caponi, Aldo Paolicchi, MD, Mario Petrini, PhD MD Prof
Journal: Blood
Blood (2017) 130 (Supplement 1): 4867.
https://doi.org/10.1182/blood.V130.Suppl_1.4867.4867
Published: 2017
Journal Articles

Non Pegylated Liposomal Doxorubicin in Combination with Dexamethasone and Lenalidomide (RMD) Is Active in Advanced MM

Gabriele Buda, MD, Enrico Orciuolo, Martina Rousseau, Sara Galimberti, Nadia Cecconi, Mario Petrini, MD
Journal: Blood
Blood (2014) 124 (21): 5742.
https://doi.org/10.1182/blood.V124.21.5742.5742
Published: 2014
Journal Articles

Bendamustine with Rituximab Is Safe and Effective As FRONT LINE Therapy in Elderly B-CLL Patients. an ITALIAN RETROSPECTIVE MULTICENTER Experience

Luca Laurenti, MD, Francesco Autore, MD, Idanna Innocenti, Barbara Vannata, Maria Cantonetti, MD, Maria Ilaria Del Principe, Francesca Romana Mauro, Anticoli Borza Paola, Velia Bongarzoni, Stefania Ciolli, MD, Riccardo Boncompagni, Mariarita Sciumé, MD, Daniele Vincenti, MD, Francesco Ghio, MD, Nadia Cecconi, Vincenzo Pitini, Patrizia Mondello, Maria Rosa Lanza Cariccio, Alessandro Gozzetti, Giovanni D'Arena, Roberta Murru, MD, Nicola Piccirillo, Mario Petrini, MD PhD, Agostino Cortelezzi, MD, Giovanni Del Poeta, Robin Foà, MD, Simona Sica, MD
Journal: Blood
Blood (2014) 124 (21): 5655.
https://doi.org/10.1182/blood.V124.21.5655.5655
Published: 2014
Journal Articles

Efficacy and Safety Of Bendamustine In Combination With Rituximab For Elderly Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia. A Retrospective Multicenter Study

Luca Laurenti, MD, Barbara Vannata, Idanna Innocenti, Francesco Autore, Francesco Ghio, Nadia Cecconi, Vincenzo Pitini, Patrizia Mondello, Maria Rosa Lanza Cariccio, Alessandro Gozzetti, Giovanni D'Arena, Roberta Murru, MD, Nicola Piccirillo, Giuseppe Leone, MD, Simona Sica, MD
Journal: Blood
Blood (2013) 122 (21): 5309.
https://doi.org/10.1182/blood.V122.21.5309.5309
Published: 2013
Journal Articles

Safety and Efficacy of Bendamustine with or without Rituximab for the Treatment of Heavily Pretreated CLL and Lymphoma Patients. A Multicenter Retrospective Study.

Luigi Rigacci, Benedetta Puccini, Enrico Orciuolo, Alfonso D'Arco, Sergio Storti, Gianluca Gaidano, Roberto Freilone, Nicola Di Renzo, MD, Caterina Patti, MD, Alessandro Isidori, MD, PhD, Pier Luigi Zinzani, MD, Marco Gobbi, MD, Pellegrino Musto, MD, Anna Marina Liberati, MD, Andrea Carpaneto, Sergio Cortelazzo, Nicola Cascavilla, MD, Nadia Cecconi, Valeria Belsito Petrizzi, Giulio Giordano, MD, Silvia Franceschetti, Atto Billio, Alberto Bosi, MD
Journal: Blood
Blood (2009) 114 (22): 1662.
https://doi.org/10.1182/blood.V114.22.1662.1662
Published: 2009
Journal Articles

Role of Yttrium-90 Ibritumomab Tiuxetan (Zevalin®) in Inducing and Maintaining Complete Molecular Response in B Non Hodgkin’s Lymphoma Patients in Clinical Complete Remission after Chemotherapy Regimen.

Enrico Orciuolo, MD, Gabriele Buda, MD, Sara Galimberti, MD, Giuseppe Boni, MD, Nadia Cecconi, MD, Mario Petrini, MD
Journal: Blood
Blood (2007) 110 (11): 4498.
https://doi.org/10.1182/blood.V110.11.4498.4498
Published: 2007